Current Issue

View Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences

Featured Articles

Enabling Total Biopharma Solutions

Pall Life Sciences

Navigating Technology Transfer

Comparison of purification performance of Amsphere A3 to other commercially available Protein A resins

Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release

By: Jeffrey Doyle, Manager, PAT Projects in the Process Analytical Sciences Group
Paul Jeffers, Manager, PAT Projects in Process Analytical Sciences Group, Global Technology Services
Seamus O’Neill, Analytical Chemist
Pfizer

View All Featured Articles

Headline News

Allergan Aesthetics reports improved facial satisfaction in GLP-1 users after aesthetic treatments

Camzyos shows sustained benefit through 56 weeks in paediatric obstructive HCM

Onchilles reports early systemic activity with intratumoral N17350 in Phase I/II trial

Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Single-Use & Stainless Steel BioReactors: Quality Factors for Consideration When Selecting a Suitable System

Presented by Dr Trevor Deeks, Principal and Consultant of Deeks Pharmaceutical Consulting Services, LLC
08th November 2017

Implementation Strategies and Challenges for Single-Use Technologies at Commercial Scale

Presented by Adam Goldstein, Roche/Genentech and Jacob McNeil, Thermo Fisher Scientific
17th May 2018

Evolve Manufacturing Processes by Implementing Disruptive Technologies

Presented by Presented Yuyi Shen, Associate Director and Head of Development & Manufacturing at Bolt Biotherapeutics and John Cyganowski, Director of Manufacturing Sciences and Technologies Downstream Americas for MilliporeSigma
19th November 2018

View All Past Webinars

Featured Companies

View All Companies

Featured Video

At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.

There’s no kit for the perfect biotech process. Until now.

View All Videos